Brief: Selecta Biosciences Reports First Quarter 2022 Financial Results

Cartesian Therapeutics

05/05/2022 12:44

May 5 (Reuters) - Selecta Biosciences Inc  SELB.O :
    * SELECTA BIOSCIENCES REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * SELECTA HAD $118.8 MILLION IN CASH, CASH EQUIVALENTS,
MARKETABLE
SECURITIES, AND RESTRICTED CASH AS OF MARCH 31, 2022
    * QTRLY DILUTED NET INCOME PER SHARE $0.08
    * QTRLY BASIC NET INCOME PER SHARE $0.23
    * Q1 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXblvnY8 
Further company coverage:  SELB.O